Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

ConditionsMultiple Sclerosis Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Relapse Multiple Sclerosis, Relapsing-Remitting

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-75

SponsorShirley Ryan AbilityLab

About this trial

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of relapsing form of MS (including relapsing-remitting MS and secondary progressive MS)

Able to ambulate overground

Relapse free for at least 1 month

Age ≥18 and ≤ 75 years

Disqualifiers

None

Trial population

Persons with multiple sclerosis who can ambulate overground

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Camera Based Kinematic Analysis
Diagnostic test
Observational Study using Camera Based, Marker Less Kinematic Analysis of gait quality of persons with Multiple Sclerosis

Treatment groups

40 Participants

are divided into 1 treatment group

Group A: Observation1 intervention

Trial outcomes

Primary outcomes

Kinematics of the gait cycle

Joint position of lower limbs during a single cycle of gait

Time frame

at the time of session

Secondary outcomes

6 minute walk test

you will be instructed to walk as quickly and safely as you can while being timed for 6 minutes

Time frame

at the time of session

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Shirley Ryan AbilityLab

Lead sponsor

Source ClinicalTrials.gov

Apply now